286 Results (Page 3 of 12)
Middle East Markets Research Reports
Mexico Intravenous Solutions Market Analysis
Mexico intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.
Mexico Irritable Bowel Syndrome Drugs Market Analysis
Mexico irritable bowel syndrome drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased illness awareness, the expected timely availability of recently approved drugs, an enhanced payment system, and rising IBS prevalence are the main market drivers for IBS-D pharmaceuticals. The key players in this market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.
Mexico Isoflavones Market Analysis
Mexico isoflavones drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is primarily driven by three factors: the growing elderly population, technological developments in the production of isoflavones, and the rising prevalence of cancer and other chronic disorders. The major key players in this market are Cargill, BASF, DSM, Shanghai Freemen, and ADM. Other key players include Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Avestia Pharma, NutraScience Labs, Tradichem S.L., Nutra Green Biotechnology.
Mexico Kidney Cancer Drugs Market Analysis
Mexico kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.
Mexico Knee Cartilage Repair Market Analysis
Mexico knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.
Mexico Lactoferrin Market Analysis
Mexico lactoferrin market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology advances that enable effective operational maintenance, efficient production, an extended product line, elegant design and packaging, and sales monitoring are key growth factors for the lactoferrin industry. The major key players in this market are Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-tech LLC.
Mexico Lipid Lowering Drugs Market Analysis
Mexico lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.
Mexico Liver Cancer Drugs Market Analysis
Mexico liver cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising incidence of liver cancer and the accessibility of novel medications are the two main drivers of market expansion over the forecast period. In the upcoming years, market expansion is anticipated to be fueled by increased investments in the research & development industry and the discovery of novel medicines. The major key players in this market are Bayer HealthCare Pharmaceuticals Inc. (Germany), Bristol-Myers & Squibb Company (US), Pfizer Inc. (US), Exelixis, Inc. (US), Merck Sharp & Dohme Corp. (US), Eisai Inc. (Japan), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland).
Mexico Mammography Device Market Analysis
Mexico mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.
Mexico Medical Cannabis Drugs Market Analysis
Mexico medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.
Mexico Medical Electronics Market Analysis
Mexico medical electronics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence and prevalence of chronic diseases, the growing elderly population, and the expanding use of machine vision are the few factors that will affect medical electronic market. The increased incidence of chronic diseases like cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others is the main factor driving market expansion. Some of the major key players in this market are Analog Devices, Inc., Texas Instruments Incorporated., Medtronic, STMicroelectronics, Mouser Electronics, Inc., etc.
Mexico Medical Imaging Market Analysis
Mexico medical imaging market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Teaching hospitals and universities are projected to need more modern imaging modalities in order to train students in cutting-edge technology, which is anticipated to have a significant impact on market growth. The major key players in this market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corp., Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc.
Mexico Medical Information Market Analysis
Mexico medical information market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to grow due to the increase in demand for the creation of new drugs, the creation of technologically advanced healthcare solutions, and the ease with which information about healthcare products can be accessed. The major key players in this market are Accenture Plc, Change Healthcare Inc., Cognizant Technology Solutions Corp., Ergomed Plc, HCL Technologies Ltd., Infosys Ltd., IQVIA Holdings Inc., MakroCare, Parexel International Corp., ProPharma Group Holdings LLC.
Mexico Medical X-ray Market Analysis
Mexico medical X-ray market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. One of the key factors driving the expansion of the medical X-ray market is the rising incidence of bone fractures. Other indirect market growth factors include increased personal disposable income, increasing rates of traffic accidents, and rising costs for R&D operations. Some of the major key players in this market are General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Carestream Health., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., etc.
Mexico Melanoma Drugs Market Analysis
Mexico melanoma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. This market is growing as a result of factors like an increase in melanoma incidence, greater awareness of available melanoma diagnostic and treatment options, and technological advancements in melanoma drugs. The major key players in this market are Novartis, Roche Holding AG, GlaxoSmithKline, Pfizer, Merck Group, Bristol Myers Squibb (BMY), Amgen, Genentech, Eisai Co. Ltd, Janssen Biotech, BeiGene Ltd, Iovance Biotherapeutics Inc., AB Science, Grand Pharmaceutical Group Co., Ltd. and, Navidea Biopharmaceuticals.
Mexico Meningococcal Vaccines Market Analysis
Mexico meningococcal vaccines market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Mexico Metabolic Disorder Drugs Market Analysis
Mexico metabolic disorder drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The ageing population, rising diabetes and obesity rates, and the prevalence of metabolic disorders are all driving factors for the global market for medications treating these conditions. Another element fueling the expansion of this market is an increase in public awareness of various ailments and associated pharmacological treatments. Some of the major key players in this market are AbbVie, Actelion Pharmaceuticals, Amgen, Astra Zeneca, Biocon, BioMarin Pharmaceutical, etc.
Mexico Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis
Mexico Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.
Mexico Microspheres Market Analysis
Mexico microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.
Mexico Migraine Drugs Market Analysis
Mexico migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.
Mexico Multiple Myeloma Drugs Market Analysis
Mexico multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.
Mexico Nanomedicine Market Analysis
Mexico nanomedicine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Shortly, significant advancements and the recent commercialization of goods like mRNA- and liposome-based vaccines are anticipated to fuel the rise of nanomedicines. The major key players in this market are Abbott Laboratories, CombiMatrix Corporation, Celgene Corporation, etc.
Mexico Nanotechnology Drugs Delivery Market Analysis
Mexico nanotechnology drugs delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for nanotechnology medication delivery is heavily influenced by factors like expanding public awareness of nanotechnology, an increase in the prevalence of chronic illnesses, technological improvement, and rising government investment in nanotechnology in various emerging nations. The major key players in this market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG.
Mexico NSCLC Drugs Market Analysis
Mexico NSCLC Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. During the projection period, the global non-small cell lung cancer market will grow due to the rise in cancer cases worldwide. Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market.The global NSCLC Drugs market’s major key players are AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, Novartis AG, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson.
Mexico Oncology Biosimilars Market Analysis
Mexico oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.